Literature DB >> 9854443

The representation of sublexical orthographic-phonologic correspondences: evidence from phonological dyslexia.

M F Lesch1, R C Martin.   

Abstract

Although there is considerable evidence that grapheme and body units are involved in assembling phonology from print, there is little evidence supporting the involvement of syllabic representations. We provide evidence on this point from a phonological dyslexic patient (ML) who, as a result of brain damage, is relatively unable to read nonwords. ML was found to be able to perform tasks assumed to reflect processes involved in assembled phonology (i.e. segmentation, orthographic-phonologic conversion, and blending) when the units involved were syllables, but demonstrated considerable difficulty when they were onset, body, or phoneme units. Additionally, both ML and matched controls were much better able to find words in an anagrams task (Treiman & Chafetz, 1987) when they resulted from the combination of segments corresponding to syllables than when they did not. It is suggested that the relationship between print and sound is represented at multiple levels (including the syllable) (Shallice, Warrington, & McCarthy, 1983) and that ML's nonword reading impairment is the result of disruption of representations below the level of the syllable.

Entities:  

Mesh:

Year:  1998        PMID: 9854443     DOI: 10.1080/713755790

Source DB:  PubMed          Journal:  Q J Exp Psychol A        ISSN: 0272-4987


  2 in total

1.  Elaborative feedback: Engaging reward and task-relevant brain regions promotes learning in pseudoword reading aloud.

Authors:  Samantha R Mattheiss; Edward J Alexander; William W Graves
Journal:  Cogn Affect Behav Neurosci       Date:  2018-02       Impact factor: 3.282

2.  Phonological and surface dyslexia in individuals with brain tumors: Performance pre-, intra-, immediately post-surgery and at follow-up.

Authors:  Barbara Tomasino; Tamara Ius; Miran Skrap; Claudio Luzzatti
Journal:  Hum Brain Mapp       Date:  2020-08-28       Impact factor: 5.038

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.